Search results for “our global team”
HRI celebrates 35 years of groundbreaking research
The Heart Research Institute (HRI) is celebrating 35 years of world-renowned research.
Dr Carmine Gentile and his research team join HRI
The Heart Research Institute (HRI) is thrilled to welcome the Cardiovascular Regeneration Group, led by Dr Carmine Gentile, to the team.
HRI researchers honoured as finalists for prestigious mentor award
Congratulations to two of HRI's leading researchers, Prof Ben Freedman OAM and Assoc Prof Mary Kavurma, who were among the four finalists for the 2023 Australian Cardiovascular Alliance (ACvA) Mentor Award.
Cardiovascular Regeneration
Our mission is to investigate the pathophysiological aspects of cardiovascular diseases and the development of tissue engineering solutions for regeneration.
Join our Team
Enjoy the career benefits of work and study with international leaders in the field of cardiovascular research.
Double win for Jessica Orchard
Congratulations to Jessica Orchard on winning an educational grant for the European Heart Rhythm Association 2020 Congress as well as the Emerging Researchers in Mobile Health Prize at eHealth@Sydney 2020.
Why work at HRI?
HRI is an internationally recognised medical research institute with global collaborations.
Targeted therapy for type 2 diabetes
Type 2 diabetes (T2D) is a global epidemic.
Inactivity and a sedentary lifestyle
Lifestyles have become more sedentary, and this inactivity can negatively impact health.
HRI announces novel anti-clotting drug to help critically ill COVID-19 patients
HRI is on the precipice of a significant research breakthrough for the treatment of one of the major life-threatening complications of the novel coronavirus (COVID-19), microscopic blood clots.
HRI sheds further light on relationship between diet and cardiometabolic disease
Recent HRI research has validated the metabolic pathways that link dietary components with the risk of developing cardiovascular disease.
HRI researchers on cusp of worldwide breakthrough in COVID-19 treatment
Researchers at HRI believe they may hold the key to controlling the deadly blood clots caused by COVID-19.
World first: risk of dementia linked to high cholesterol
HRI has made a world-first breakthrough discovery, linking high cholesterol with an increased risk of dementia for the first time.
Illuminate 2017: Celebrating science and curiosity
The Heart Research Institute’s annual Awards for Excellence dinner, Illuminate, was recently held to celebrate and recognise some of our most up-and-coming scientists and showcase to our supporters some of the advances we are making in our mission to fight cardiovascular disease.
Revolutionising new treatment options for stroke
HRI has been awarded an almost $1 million Cardiovascular Research Capacity Program grant to revolutionise treatment options for stroke.
World-first clinical trials begin for promising new anti-clotting stroke drug
HRI has made a breakthrough 25 years in the making, identifying and developing a new anti-clotting drug that shows great promise in the treatment of stroke.
HRI at the forefront of a global push for stroke screen
Older people should be routinely screened for an irregular heartbeat to prevent thousands of strokes worldwide each year, a top-level expert panel of health specialists has urged.
Prof Ben Freedman wins prestigious ministerial award for cardiovascular research
Congratulations to Prof Ben Freedman OAM, who has been awarded the prestigious 2023 Ministerial Award for Cardiovascular Research.
World-leading researcher in atherosclerosis to join HRI
World-leading researcher in atherosclerosis, Dr Tessa Barrett, will lead a new research group at HRI, funded by a prestigious NSW Cardiovascular Elite Postdoctoral Researcher Grant from NSW Health and HRI’s Robert Edward Gough Fellowship.
Photo-responsive thrombin inhibitors enable precise control of localised antithrombotic therapy
This project investigates the transformation of a direct thrombin inhibitor into a photo-responsive therapy for stroke, with the aim to precisely control local anticoagulation using two-photon excitation lasers.
Celebrating the career of Prof Roland Stocker
HRI sends Prof Roland Stocker the warmest well wishes for his retirement and sincere gratitude for his immense contributions to science, in particular cardiovascular disease research.
HRI celebrates International Women’s Day 2024
The Heart Research Institute (HRI) celebrated International Women’s Day (IWD) and gender equity with an inspiring seminar featuring three amazing women.
It’s a hat-trick: three significant HRI NZ grants awarded
HRI is delighted to announce the award of three grants funded by HRI donors to support research into cardiovascular disease – the world’s biggest killer.